Potential role of LPAR5 gene in prognosis and immunity of thyroid papillary carcinoma and pan-cancer

Abstract Papillary carcinomas account for the largest proportion of thyroid cancers, with papillary thyroid carcinoma (PTC) being prone to early lymph node metastasis. Some studies have confirmed that LPAR5 can promote the progression of PTC, but immune-related analyses of LPAR5 and PTC have not bee...

Full description

Bibliographic Details
Main Authors: Ben Zhang, Lixi Zhang, Peng Qi, Renzhu Pang, Ziming Wang, Xuyao Liu, Qi Shi, Qiang Zhang
Format: Article
Language:English
Published: Nature Portfolio 2023-04-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-023-32733-y
_version_ 1797845989154881536
author Ben Zhang
Lixi Zhang
Peng Qi
Renzhu Pang
Ziming Wang
Xuyao Liu
Qi Shi
Qiang Zhang
author_facet Ben Zhang
Lixi Zhang
Peng Qi
Renzhu Pang
Ziming Wang
Xuyao Liu
Qi Shi
Qiang Zhang
author_sort Ben Zhang
collection DOAJ
description Abstract Papillary carcinomas account for the largest proportion of thyroid cancers, with papillary thyroid carcinoma (PTC) being prone to early lymph node metastasis. Some studies have confirmed that LPAR5 can promote the progression of PTC, but immune-related analyses of LPAR5 and PTC have not been widely discussed. This study aimed to determine the role of LPAR5 in PTC prognosis and immunity. We will further explore the role of LPAR5 in 33 different tumor types. Regarding PTC, we analyzed the effect of LPAR5 expression on overall survival (OS). Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses were performed. Immune-related analyses of immune checkpoints (ICPs) and immune cell infiltration were also performed. For pan-cancer, R packages were used to analyze prognosis, tumor mutational burden (TMB), microsatellite instability (MSI), and immune cell infiltration. Analysis of tumor microenvironment (TME) and ICPs was performed using Sangerbox ( http://vip.sangerbox.com/home.html ). The TISIDB database ( http://cis.hku.hk/TISIDB/index.php ) was used to identify immune and molecular subtypes. LPAR5 expression is associated with PTC prognosis and immunity as well as various human tumors. LPAR5 may be a potential biomarker for multiple malignancies and may provide a new target for cancer immunotherapy.
first_indexed 2024-04-09T17:47:49Z
format Article
id doaj.art-0bf29e985bdc4129be95c27aa14c540b
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-04-09T17:47:49Z
publishDate 2023-04-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-0bf29e985bdc4129be95c27aa14c540b2023-04-16T11:11:47ZengNature PortfolioScientific Reports2045-23222023-04-0113111410.1038/s41598-023-32733-yPotential role of LPAR5 gene in prognosis and immunity of thyroid papillary carcinoma and pan-cancerBen Zhang0Lixi Zhang1Peng Qi2Renzhu Pang3Ziming Wang4Xuyao Liu5Qi Shi6Qiang Zhang7Thyroid Surgery Department, General Surgery Center, First Hospital of Jilin UniversityThyroid Surgery Department, General Surgery Center, First Hospital of Jilin UniversityThyroid Surgery Department, General Surgery Center, First Hospital of Jilin UniversityThyroid Surgery Department, General Surgery Center, First Hospital of Jilin UniversityThyroid Surgery Department, General Surgery Center, First Hospital of Jilin UniversityThyroid Surgery Department, General Surgery Center, First Hospital of Jilin UniversityThyroid Surgery Department, General Surgery Center, First Hospital of Jilin UniversityThyroid Surgery Department, General Surgery Center, First Hospital of Jilin UniversityAbstract Papillary carcinomas account for the largest proportion of thyroid cancers, with papillary thyroid carcinoma (PTC) being prone to early lymph node metastasis. Some studies have confirmed that LPAR5 can promote the progression of PTC, but immune-related analyses of LPAR5 and PTC have not been widely discussed. This study aimed to determine the role of LPAR5 in PTC prognosis and immunity. We will further explore the role of LPAR5 in 33 different tumor types. Regarding PTC, we analyzed the effect of LPAR5 expression on overall survival (OS). Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses were performed. Immune-related analyses of immune checkpoints (ICPs) and immune cell infiltration were also performed. For pan-cancer, R packages were used to analyze prognosis, tumor mutational burden (TMB), microsatellite instability (MSI), and immune cell infiltration. Analysis of tumor microenvironment (TME) and ICPs was performed using Sangerbox ( http://vip.sangerbox.com/home.html ). The TISIDB database ( http://cis.hku.hk/TISIDB/index.php ) was used to identify immune and molecular subtypes. LPAR5 expression is associated with PTC prognosis and immunity as well as various human tumors. LPAR5 may be a potential biomarker for multiple malignancies and may provide a new target for cancer immunotherapy.https://doi.org/10.1038/s41598-023-32733-y
spellingShingle Ben Zhang
Lixi Zhang
Peng Qi
Renzhu Pang
Ziming Wang
Xuyao Liu
Qi Shi
Qiang Zhang
Potential role of LPAR5 gene in prognosis and immunity of thyroid papillary carcinoma and pan-cancer
Scientific Reports
title Potential role of LPAR5 gene in prognosis and immunity of thyroid papillary carcinoma and pan-cancer
title_full Potential role of LPAR5 gene in prognosis and immunity of thyroid papillary carcinoma and pan-cancer
title_fullStr Potential role of LPAR5 gene in prognosis and immunity of thyroid papillary carcinoma and pan-cancer
title_full_unstemmed Potential role of LPAR5 gene in prognosis and immunity of thyroid papillary carcinoma and pan-cancer
title_short Potential role of LPAR5 gene in prognosis and immunity of thyroid papillary carcinoma and pan-cancer
title_sort potential role of lpar5 gene in prognosis and immunity of thyroid papillary carcinoma and pan cancer
url https://doi.org/10.1038/s41598-023-32733-y
work_keys_str_mv AT benzhang potentialroleoflpar5geneinprognosisandimmunityofthyroidpapillarycarcinomaandpancancer
AT lixizhang potentialroleoflpar5geneinprognosisandimmunityofthyroidpapillarycarcinomaandpancancer
AT pengqi potentialroleoflpar5geneinprognosisandimmunityofthyroidpapillarycarcinomaandpancancer
AT renzhupang potentialroleoflpar5geneinprognosisandimmunityofthyroidpapillarycarcinomaandpancancer
AT zimingwang potentialroleoflpar5geneinprognosisandimmunityofthyroidpapillarycarcinomaandpancancer
AT xuyaoliu potentialroleoflpar5geneinprognosisandimmunityofthyroidpapillarycarcinomaandpancancer
AT qishi potentialroleoflpar5geneinprognosisandimmunityofthyroidpapillarycarcinomaandpancancer
AT qiangzhang potentialroleoflpar5geneinprognosisandimmunityofthyroidpapillarycarcinomaandpancancer